Kliniko-haemodynamic results after mitral valve prosthetics of heart, correction of the hemostasis by anticoagulants

Cover Page

Abstract


Correction of hem stasis disbalance was contacted for 57 patients after mitral valve prosthetics. The average age of the patients was - 45,18 ± 1,14, duration of observation was 3,57 ± 2,8. OAC -Warfarin (Nycomed) was given to patients after PMV. This patients need constant correction of symptoms of failure and screening of the dose anticoagulant in accordance with INR (2,0-3,0). Insufficient hypo coagulation increased risk of thromboembolic complication: signs of trombinemia were noted. Correction of hem stasis disbalance included prescription of the course of low molecular-wight heparini during 7-10 days with simultaneous increase of the doses of Warfarini in order to rich INR therapeutic level during 3-5 days. Cardiomagnili 75 mg every day (n = 24) was added to patients hair risk development of the systemic embolism. Tendency of little bleeding was noted: three cases of gums bleeding, too cases of microhematuria one case of spitting blood.

About the authors

N V Chilikina

The Moscow state mediko-stomatologic university

Кафедра терапии № 1; ФПДО Московский государственныймедико-стоматологический университет; The Moscow state mediko-stomatologic university

G V Arkadeva

The Moscow state mediko-stomatologic university

Кафедра терапии № 1; ФПДО Московский государственныймедико-стоматологический университет; The Moscow state mediko-stomatologic university

A E Radzevich

The Moscow state mediko-stomatologic university

Кафедра терапии № 1; ФПДО Московский государственныймедико-стоматологический университет; The Moscow state mediko-stomatologic university

References

Statistics

Views

Abstract - 92

PDF (Russian) - 42

Cited-By



Copyright (c) 2010 Чиликина Н.В., Аркадьева Г.В., Радзевич А.Э.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies